J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 552, Number 2, 571-587, October 15, 2003 DOI: 10.1113/jphysiol.2003.049122
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
552/2/571    most recent
jphysiol.2003.049122v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Owyang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Owyang, C.
J Physiol (2003), 552.2, pp. 571-587
© Copyright 2003 D 2003 The Physiological Society
DOI: 10.1113/jphysiol.2003.049122

Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat

Ying Li, Xiaoyin Wu, Jinxia Zhu, Jin Yan and Chung Owyang

Gastroenterology Research Unit, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109, USA

The vago-vagal reflex plays an important role in mediating pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent luminal factors. We hypothesize that the vago-vagal reflex mediating pancreatic secretion in the rat is under central control and regulated by cholinergic pathways in the hypothalamus. To test this hypothesis, we demonstrated that chronic decerebration decreased basal pancreatic enzyme secretion from 318 ± 12 to 233 ± 9 mg h-1 and reduced the net increase in pancreatic secretion stimulated by intraduodenal infusion of 5 % peptone and hypertonic NaCl by 54 % and 45 %, respectively. Intracerebroventricular administration of methscopolamine (MSCP, 50 nmol (5 µl)-1), a blood-brain barrier-impermeant cholinergic muscarinic receptor antagonist, evoked results similar to those achieved by chronic decerebration. To localize the sites of action, we demonstrated that microinjection of MSCP (20 nmol) into the lateral hypothalamic nucleus or the paraventricular nucleus resulted in inhibition of both basal pancreatic protein secretion and luminally stimulated pancreatic secretion by 48 % and 52 %, respectively. Intracerebroventricular injection of hemicholinium-3 at doses known to deplete the endogenous ACh store produced similar inhibitory results. In addition, microinjection of ACh (5 pmol) or the muscarinic M1 receptor agonist McN-A-343 (30 ng) into the lateral hypothalamic nucleus increased pancreatic secretion over basal levels by 46 % and 40 %, respectively. Selective lesions of lateral septal cholinergic neurons decreased basal pancreatic secretion and inhibited peptone-induced pancreatic secretion by 30 %. Destruction of the lateral parabrachial nucleus produced a 44 % inhibition of peptone-induced pancreatic section. Finally, microinjection of glutamate into the lateral septum or the lateral parabrachial nucleus stimulated vagal pancreatic efferent nerve firings from a basal level of 0 ± 0.5 impulses (30 s)-1 to 4.5 ± 0.5 and 14 ± 2 impulses (30 s)-1, respectively, and pancreatic protein output increased 50 % and 84 % over basal levels. Administration of MSCP to the paraventricular nucleus eliminated these effects. These observations suggest that cholinergic neurons of the lateral septum and lateral parabrachial nucleus regulate pancreatic secretion. Further, cholinergic input from the lateral parabrachial nucleus to the hypothalamus plays a major role in the modulation of vagal pancreatic efferent nerve activity and pancreatic secretion evoked by the vago-vagal reflex.



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. L. Chen, X. Y. Wu, Z. J. Cao, J. Fan, M. Wang, C. Owyang, and Y. Li
Subdiaphragmatic vagal afferent nerves modulate visceral pain
Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1441 - G1449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Li, X. Wu, Y. Zhao, S. Chen, and C. Owyang
Ghrelin acts on the dorsal vagal complex to stimulate pancreatic protein secretion
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1350 - G1358.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. A. Pavlov, M. Ochani, M. Gallowitsch-Puerta, K. Ochani, J. M. Huston, C. J. Czura, Y. Al-Abed, and K. J. Tracey
Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia
PNAS, March 28, 2006; 103(13): 5219 - 5223.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
X. Wu, J. Gao, J. Yan, C. Owyang, and Y. Li
Hypothalamus-Brain Stem Circuitry Responsible for Vagal Efferent Signaling to the Pancreas Evoked By Hypoglycemia in Rat
J Neurophysiol, April 1, 2004; 91(4): 1734 - 1747.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 The Physiological Society.